These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8614448)

  • 21. Calculating excess risk with age-dependent adjustment factors and cumulative doses: ethylene oxide case study.
    Sielken RL; Flores CV
    Regul Toxicol Pharmacol; 2009 Oct; 55(1):76-81. PubMed ID: 19508881
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trichloroethylene health risks--state of the science.
    Scott CS; Cogliano VJ
    Environ Health Perspect; 2000 May; 108 Suppl 2(Suppl 2):159-60. PubMed ID: 10928830
    [No Abstract]   [Full Text] [Related]  

  • 23. Cancer risk assessment of direct acting carcinogens.
    Zito R
    J Exp Clin Cancer Res; 1999 Sep; 18(3):273-8. PubMed ID: 10606168
    [No Abstract]   [Full Text] [Related]  

  • 24. Scientific risk assessment and the regulation of human cancer risks: background and new directions.
    Barnard RC
    Am Ind Hyg Assoc J; 1987 Sep; 48(9):798-803. PubMed ID: 3687740
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Environmental health. Second look at arsenic finds higher risk.
    Kaiser J
    Science; 2001 Sep; 293(5538):2189. PubMed ID: 11567118
    [No Abstract]   [Full Text] [Related]  

  • 26. Potential new approaches for children's inhalation risk assessment.
    Firestone M; Sonawane B; Barone S; Salmon AG; Brown JP; Hattis D; Woodruff T
    J Toxicol Environ Health A; 2008; 71(3):208-17. PubMed ID: 18097946
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radon guidelines miss the mark.
    Pelley J
    Environ Sci Technol; 2007 Feb; 41(3):670-1. PubMed ID: 17328163
    [No Abstract]   [Full Text] [Related]  

  • 28. US Environmental Protection Agency's revised guidelines for Carcinogen Risk Assessment: incorporating mode of action data.
    Dellarco VL; Wiltse JA
    Mutat Res; 1998 Sep; 405(2):273-7. PubMed ID: 9748625
    [No Abstract]   [Full Text] [Related]  

  • 29. U.S. EPA's IRIS assessment of 2-butoxyethanol: the relationship of noncancer to cancer effects.
    Gift JS
    Toxicol Lett; 2005 Mar; 156(1):163-78. PubMed ID: 15705494
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Public health. Arsenic epidemiology and drinking water standards.
    Smith AH; Lopipero PA; Bates MN; Steinmaus CM
    Science; 2002 Jun; 296(5576):2145-6. PubMed ID: 12077388
    [No Abstract]   [Full Text] [Related]  

  • 31. An air quality data analysis system for interrelating effects, standards, and needed source reductions.
    Lippmann M
    J Air Waste Manag Assoc; 2003 Nov; 53(11):1298-300; author reply 1300. PubMed ID: 14649748
    [No Abstract]   [Full Text] [Related]  

  • 32. U.S. Environmental Protection Agency's revised cancer guidelines for carcinogen risk assessment.
    Andersen M; Brusick D; Cohen S; Dragan Y; Frederick C; Goodman JI; Hard G; Meek B; O'Flaherty EJ
    Toxicol Appl Pharmacol; 1998 Nov; 153(1):133-6. PubMed ID: 9875307
    [No Abstract]   [Full Text] [Related]  

  • 33. Risk assessment reappraisals.
    Science; 1988 May; 240(4856):1125-6. PubMed ID: 3375805
    [No Abstract]   [Full Text] [Related]  

  • 34. Calculation of cancer risk.
    Walker B
    Environ Health Perspect; 1997 Jan; 105(1):15-6. PubMed ID: 9074866
    [No Abstract]   [Full Text] [Related]  

  • 35. Critical evaluation of the cancer risk of dibromochloropropane (DBCP).
    Clark HA; Snedeker SM
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2005; 23(2):215-60. PubMed ID: 16291528
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carcinogens and human health: Part 3.
    Cogliano VJ; Farland WH; Preuss PW; Wiltse JA; Rhomberg LR; Chen CW; Mass MJ; Nosnow S; White PD; Parker JC
    Science; 1991 Feb; 251(4994):606-8. PubMed ID: 1992511
    [No Abstract]   [Full Text] [Related]  

  • 37. 1982 Herbert E. Stokinger lecture ... the real world- or science fiction.
    Elkins HB
    Am Ind Hyg Assoc J; 1982 Oct; 43(10):717-21. PubMed ID: 7148679
    [No Abstract]   [Full Text] [Related]  

  • 38. A simple method for quantitative risk assessment of non-threshold carcinogens based on the dose descriptor T25.
    Sanner T; Dybing E; Willems MI; Kroese ED
    Pharmacol Toxicol; 2001 Jun; 88(6):331-41. PubMed ID: 11453374
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanistic and epidemiologic data: when is enough enough?
    Roberts R; Ashby J
    Environ Health Perspect; 2002 Sep; 110(9):A502-3. PubMed ID: 12269288
    [No Abstract]   [Full Text] [Related]  

  • 40. An evaluation of the mode of action framework for mutagenic carcinogens case study: Cyclophosphamide.
    McCarroll N; Keshava N; Cimino M; Chu M; Dearfield K; Keshava C; Kligerman A; Owen R; Protzel A; Putzrath R; Schoeny R
    Environ Mol Mutagen; 2008 Mar; 49(2):117-31. PubMed ID: 18240158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.